A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment.
Marathe, Bindumadhav M
A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment. [electronic resource] - Antiviral research Dec 2017 - 20-31 p. digital
Publication Type: Journal Article
1872-9096
10.1016/j.antiviral.2017.10.021 doi
Animals
Antiviral Agents--pharmacology
Cell Line
Disease Models, Animal
Dogs
Humans
Immunocompromised Host
Influenza B virus--classification
Lung--immunology
Madin Darby Canine Kidney Cells
Mice
Mice, Inbred BALB C
Neuraminidase--antagonists & inhibitors
Orthomyxoviridae Infections--drug therapy
Oseltamivir--pharmacology
Treatment Outcome
Viral Load--drug effects
Virulence--drug effects
Virus Replication--drug effects
A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment. [electronic resource] - Antiviral research Dec 2017 - 20-31 p. digital
Publication Type: Journal Article
1872-9096
10.1016/j.antiviral.2017.10.021 doi
Animals
Antiviral Agents--pharmacology
Cell Line
Disease Models, Animal
Dogs
Humans
Immunocompromised Host
Influenza B virus--classification
Lung--immunology
Madin Darby Canine Kidney Cells
Mice
Mice, Inbred BALB C
Neuraminidase--antagonists & inhibitors
Orthomyxoviridae Infections--drug therapy
Oseltamivir--pharmacology
Treatment Outcome
Viral Load--drug effects
Virulence--drug effects
Virus Replication--drug effects